CoChat
Sign Up
Cited by 191Opioid Use Disorder TreatmentPrenatal Substance Exposure EffectsPregnancy and Medication Impact

The DOI matches its Crossref record; 132 of the 137 references it cites were found in a registry or an index.

Treatment of opioid-dependent pregnant women: Clinical and research issues

Open access
Jones, Hendree E., Martin, Peter R., Heil, Sarah H., Kaltenbach, Karol, Selby, Peter, Coyle, Mara G., Stine, Susan M., O'Grady, Kevin E., Arria, Amelia M., Fischer, Gabriele·2008·Journal of Substance Abuse Treatment
DOI 10.1016/j.jsat.2007.10.007PMC PMC2633026
Open this paper in CoChat — free account

Abstract

This article addresses common questions that clinicians face when treating pregnant women with opioid dependence. Guidance, based on both research evidence and the collective clinical experience of the authors, which include investigators in the Maternal Opioid Treatment: Human Experimental Research (MOTHER) project, is provided to aid clinical decision making. The MOTHER project is a double-blind, double-dummy, flexible-dosing, parallel-group clinical trial examining the comparative safety and efficacy of methadone and buprenorphine for the treatment of opioid dependence in pregnant women and their neonates. The article begins with a discussion of appropriate assessment during pregnancy and then addresses clinical management stages including maintenance medication selection, induction, and stabilization; opioid agonist medication management before, during, and after delivery; pain management; breast-feeding; and transfer to aftercare. Lastly, other important clinical issues including managing co-occurring psychiatric disorders and medication interactions are discussed.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jsat.2007.10.007

Cites

132 of 132 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 137 references

Research works printed but not linked: 1

  1. Gazaway, 1993, The influence of pregnancy upon trough plasma levels of methadone and its opioid effects, NIDA research monograph, 132, 112

Cited by

Sorted by citations

Items 101–191 of 191

Related

See all

Metadata

Authors
Jones, H. E., Martin, P. R., Heil, S. H., Kaltenbach, K., Selby, P., Coyle, M. G., Stine, S. M., O'Grady, K. E., Arria, A. M., & Fischer, G.
Affiliations
  • Vanderbilt University (US)
  • University of Vermont (US)
  • Thomas Jefferson University (US)
  • University of Toronto (CA)
  • Brown University (US)
  • Wayne State University (US)
  • University of Maryland, College Park (US)
  • Medical University of Vienna (AT)
ORCID
Venue
Journal of Substance Abuse Treatment
Publisher
Elsevier BV
Published
2008-10
Volume
35
Issue
3
Pages
245-259
ISSN
0740-5472 (ISSN-L)
DOI
10.1016/j.jsat.2007.10.007
PMC
PMC2633026
OpenAlex
W2094830932
Cited by
191
References
137
Citations by year
2026: 4 · 2025: 9 · 2024: 10 · 2023: 4 · 2022: 6 · 2021: 9 · 2020: 12 · 2019: 16 · 2018: 16 · 2017: 10 · 2016: 4 · 2015: 8 · 2014: 9 · 2013: 8 · 2012: 16
FWCI
2.50
Type
journal article
Language
en
Open access
Licence
Locations
  • Journal of Substance Abuse Treatment (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Rice University
  • University of Vermont
  • Universität Wien
  • National Institute on Drug Abuse (R01 DA15832, R01DA015778, R01DA015764, R01DA 0184103, R01DA015713, R01DA 0175138, R01DA015832, R01DA015741, R01DA015738, R01DA018410, R01DA018417)
  • National Center for Research Resources (M01RR000095, M01RR000109, M01-RR-00095)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
Keywords
opioid use disorder, pregnancy, maternal opioid treatment, methadone, buprenorphine, neonatal outcomes, induction, stabilization, pain management, breastfeeding, follow-up care, psychiatric comorbidity, drug interactions, clinical decision-making
MeSH terms
Analgesics, Opioid, Buprenorphine, Clinical Trials as Topic, Decision Making, Female, Humans, Infant, Newborn, Methadone, Opioid-Related Disorders, Pain, Pregnancy, Pregnancy Complications

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review